Outcome measure | Group | Baseline | Initiation of RCT | Mid-trial | End of trial |
---|---|---|---|---|---|
FABQ 1/42* | Attention-control | 14.7 ± 8.5 (11.5 to 17.9) | 14.0 ± 9.0 (10.5 to 17.4) | 7.8 ± 8.5 (4.4 to 11.1) | 8.8 ± 9.5(5.2 to 12.4) |
 | SMT | 10.4 ± 9.2 (7.2 to 13.6) | 10.5 ± 8.1 (7.7 to 13.3) | 6.9 ± 7.8 (4.2 to 9.6) | 6.2 ± 8.1 (3.5 to 9.0) |
 | SMT + Exercises | 11 ± 11.0 (7.2 to 14.8) | 7.6 ± 8.7 (4.5 to 10.6) | 6.1 ± 9.0 (3.2 to 9.2) | 4.7 ± 9.5 (1.5 to 8.0) |
FABQ 2/24** | Attention-control | 8.2 ± 7.4 (5.5 to 11.0) | 7.7 ± 7.4 (4.9 to 10.5) | 7.2 ± 6.9 (4.6 to 9.8) | 5.4 ± 5.8 (3.2 to 7.6) |
 | SMT | 7.2 ± 6.1 (5.1 to 9.3) | 6.2 ± 6.6 (3.9 to 8.5) | 4.8 ± 6.1 (2.7 to 6.9) | 5.7 ± 5.2 (3.9 to 7.5) |
 | SMT + Exercises | 7.7 ± 7.8 (5.0 to 10.4) | 5.8 ± 7.2 (3.2 to 8.3) | 3.3 ± 6.6 (1.0 to 5.6) | 2.0 ± 5.8 (0.1 to 4.0) |
SF-12 (physical) | Attention-control | 47.3 ± 8.5 (44.2 to 50.5) | 47.5 ± 9.0 (44.1 to 50.9) | 50.5 ± 9.3 (47.1 to 54.0) | 52.1 ± 8.2 (49.0 to 55.2) |
 | SMT | 48.9 ± 6.4 (46.7 to 51.1) | 52.1 ± 8.4 (49.8 to 55.0) | 51.1 ± 7.8 (48.5 to 53.8) | 53.1 ± 6.9 (50.7 to 55.5) |
 | SMT + Exercises | 49.9 ± 8.7 (47.0 to 52.9) | 51.7 ± 7.8 (49.1 to 54.4) | 52.1 ± 7.8 (49.5 to 54.8) | 54.1 ± 7.2 (51.7 to 56.6) |
SF-12 (mental) | Attention-control | 51.3 ± 9.3 (47.7 to 54.8) | 51.0 ± 11.9 (46.4 to 55.5) | 52.6 ± 11.4 (48.2 to 56.9) | 49.9 ± 10.1 (46.1 to 53.7) |
 | SMT | 47.9 ± 9.8 (44.5 to 51.3) | 48.3 ± 10.1 (44.8 to 51.8) | 49.6 ± 9.8(46.3 to 53.0) | 52.3 ± 8.4 (49.3 to 55.2) |
 | SMT + Exercises | 47.5 ± 10.1 (43.9 to 51.0) | 47.2 ± 10.1 (43.6 to 50.7) | 48.5 ± 9.8(45.1 to 51.9) | 49.8 ± 8.7 (46.9 to 52.8) |